help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 7, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1904
A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/5/1961    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyntar, D.
Right arrow Articles by Donath, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyntar, D.
Right arrow Articles by Donath, M. Y.

Submitted on August 25, 2005
Accepted on February 27, 2006

HIGH GLUCOSE ALTERS CARDIOMYOCYTE CONTACTS AND INHIBITS MYOFIBRILLAR FORMATION

Daniela Dyntar, Pavel Sergeev, Elena Klisic, Patrice Ambühl, Marcus C. Schaub, and Marc Y. Donath*

Division of Endocrinology and Diabetes, University Hospital, Zurich, Switzerland; Institute of Pharmacology and Toxicology, University of Zurich, Switzerland; Division of Nephrology, University Hospital, Zurich, Switzerland

* To whom correspondence should be addressed. E-mail: Marc.Donath{at}usz.ch.

Context: The frequency of diabetes related heart failure is increasing along with the prevalence of diabetes. Diabetic cardiomyopathy is considered to be a distinct disease in the absence of discernable coronary artery and other defined heart disease. Previously we have shown that glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in cultivated cardiomyocytes.

Objective: Here we studied the mechanisms of diabetic cardiomyopathy in more details.

Results: Streptozotocin-induced diabetes led to a significant increase in cardiac cell apoptosis. Furthermore, cardiomyocyte contacts were reduced. In vitro, prolonged exposure of cultured adult cardiomyocytes to high glucose concentrations drastically reduced myofibrillar formation. In particular sarcomeric myosin heavy chains and cardiac {alpha}-actin were reduced whereas the non-sarcomeric smooth muscle {alpha}-actin remained unaffected. The deleterious effects of glucose on myofibril formation was prevented by antioxidative regimens.

Conclusions: Thus, a diabetic milieu leads to multiple structural alterations of the heart including apoptosis, loss of intercellular contacts and malformation of contractile structures.


Key words: Cardiomyocyte contacts • Glucose and myofibrills • Streptozotocin and myocyte apoptosis




This article has been cited by other articles:


Home page
J EndocrinolHome page
Z. Li, T. Zhang, H. Dai, G. Liu, H. Wang, Y. Sun, Y. Zhang, and Z. Ge
Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats
J. Endocrinol., March 1, 2008; 196(3): 565 - 572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society